1. Home
  2. CORT vs ARE Comparison

CORT vs ARE Comparison

Compare CORT & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

N/A

Current Price

$121.38

Market Cap

9.7B

Sector

Health Care

ML Signal

N/A

Logo Alexandria Real Estate Equities Inc.

ARE

Alexandria Real Estate Equities Inc.

N/A

Current Price

$45.58

Market Cap

7.8B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
CORT
ARE
Founded
1998
1994
Country
United States
United States
Employees
N/A
514
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
7.8B
IPO Year
2001
1997

Fundamental Metrics

Financial Performance
Metric
CORT
ARE
Price
$121.38
$45.58
Analyst Decision
Buy
Hold
Analyst Count
5
16
Target Price
★ $141.00
$52.57
AVG Volume (30 Days)
872.9K
★ 1.9M
Earning Date
11-03-2026
10-26-2026
Dividend Yield
N/A
★ 6.32%
EPS Growth
★ N/A
N/A
EPS
0.09
★ 1.68
Revenue
$761,407,000.00
★ $3,026,556,000.00
Revenue This Year
$50.53
N/A
Revenue Next Year
$48.75
N/A
P/E Ratio
$1,317.11
★ $27.14
Revenue Growth
★ 12.79
N/A
52 Week Low
$28.66
$39.41
52 Week High
$126.38
$78.54

Technical Indicators

Market Signals
Indicator
CORT
ARE
Relative Strength Index (RSI) 59.16 33.54
Support Level $108.33 $45.30
Resistance Level $123.01 $55.20
Average True Range (ATR) 5.11 1.47
MACD 0.39 -0.54
Stochastic Oscillator 83.38 12.77

Price Performance

Historical Comparison
CORT
ARE

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Share on Social Networks: